Costly eye drug drives up region’s Medicare bills
A Santa Barbara eye doctor and a drug that costs $2,000 per dose are at the center of the debate over how to control the spiraling cost of Medicare.
Vapor Hub hopes to lead the way in $3B e-cigarette market
With the U.S. Food and Drug Administration promising to impose regulations on the free-for-all e-cigarette market, Simi Valley-based Vapor Hub International is hoping to help the industry grow up.
Court certifies class-action suit over Santa Barbara insurance scam
A class-action lawsuit over whether a Santa Barbara insurance agent’s employers knew about the “churning” scam he was running and let it continue because it boosted profits is headed to trial after its class certification was upheld at the California Supreme Court in March.
Ceres faces delisting from Nasdaq
Thousand Oaks-based energy crop company Ceres could be booted from the Nasdaq stock exchange if it doesn’t get its share price back above $1 in the next six months. Ceres said that it received a letter from the Nasdaq on April 28 notifying it that because its share price has lingered below $1 for 30 Read More →
